Frontiers | Selective and brain-penetrant ACSS2 inhibitors target breast cancer brain metastatic...
Breast cancer brain metastasis (BCBM) typically results in an end-stage diagnosis and is hindered by a lack of brain-penetrant drugs. Tumors in the brain rel...
frontiersin.org